Production of recombinant erythropoietin

CAFC
  • US 5,441,868 A
  • Filed: 10/23/1987
  • Issued: 08/15/1995
  • Est. Priority Date: 12/13/1983
  • Status: Expired due to Term
First Claim
Patent Images

1. A process for the production of a glycosylated erythropoietin polypeptide having the in vivo biological property of causing bone marrow cells to increase production of reticulocytes and red blood cells comprising the steps of:

  • (a) growing, under suitable nutrient conditions, mammalian host cells transformed or transfected with an isolated DNA sequence encoding human erythropoietin; and

    (b) isolating said glycosylated erythropoietin polypeptide therefrom.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×